NOT LONG NOW! eyeforpharma Barcelona 2020. Take a look at the agenda! BONUS Q&A re: patient centricity with Paul Simms

The more I think about it, the fact that data sits in silos and is in different formats is the thing that is preventing true patient centricity, because it’s what stops you determining whether intervention X actually created result Y within the population, and hence reward the right kind of behaviour.’

PAUL SIMMS, CHAIRMAN EYEFORPHARMA… Read More NOT LONG NOW! eyeforpharma Barcelona 2020. Take a look at the agenda! BONUS Q&A re: patient centricity with Paul Simms

NIHR Funding and Support Round-up |  NIHR  |  6 September 2018

Including  >>>

Latest funding opportunities

Have your say: trial registration and timely disclosure of results

New investigators can’t apply for research funding…can they? | By Justine Tomlinson

Hear Professor Jeremy Wyatt explain why the NIHR is seeking to fund more research into digital health, and what kind of proposals we would like to see.

What are studies within a trial (SWAT)?

From the RDS desk… Read More NIHR Funding and Support Round-up |  NIHR  |  6 September 2018

The Big Trends Transforming Pharma | 28 August | eyeforpharma

Read the article here to hear from:

Sebastian Guth, Executive Vice President and Chief Marketing Officer, Bayer

Christi Shaw, Senior Vice President and President, Lilly Bio Medicines, Eli Lilly

Kris Sterkens, Company Groups Chairman, Europe, Middle East and Africa, Janssen

Julie Gerberding, EVP & Chief Patient Officer, MSD

Jim Robinson, President & COO, Alkermes

Andrin Oswald, Director of Life Sciences Partnerships, Global Health, Gates Foundation… Read More The Big Trends Transforming Pharma | 28 August | eyeforpharma

NIHR Life Sciences Industry Newsletter |  NIHR  |  30 August 2018

Record numbers take part in life sciences industry research

New recorded webinar: Our offer to the life sciences

Companies should bring their biosimilar studies to the UK. Here’s why…

NIHR partners with the British Heart Foundation in world-leading cardiovascular research

Transparent and consistent costing approach for commercial contract research

Improving CRN research activity data collection… Read More NIHR Life Sciences Industry Newsletter |  NIHR  |  30 August 2018

STAT: First Opinion |A week’s worth of perspectives by experts on science & medicine | Curated by Patrick Skerrett | 29 July

Blockchains for biomedicine and health care are coming. Buyer: be informed | By ANDY CORAVOS AND NOAH ZIMMERMAN

Are embryos people? The answer will determine the future of reproductive medicine | By ERIC J. FORMAN

A tax on medical devices makes no sense. It’s time to eliminate it for good |  By DAVID BEIER… Read More STAT: First Opinion |A week’s worth of perspectives by experts on science & medicine | Curated by Patrick Skerrett | 29 July